Cell cycle– and cell growth–regulated proteolysis of mammalian CDC6 is dependent on APC–CDH1

  1. Birgit Otzen Petersen1,3,
  2. Christian Wagener1,3,
  3. Federica Marinoni1,
  4. Edgar R. Kramer2,
  5. Marina Melixetian1,
  6. Eros Lazzerini Denchi1,
  7. Christian Gieffers2,
  8. Cristian Matteucci1,
  9. Jan-Michael Peters2, and
  10. Kristian Helin1,4
  1. 1Department of Experimental Oncology, European Institute of Oncology, 20141 Milan, Italy; 2Research Institute of Molecular Pathology, 1030 Vienna, Austria

Abstract

CDC6 is conserved during evolution and is essential and limiting for the initiation of eukaryotic DNA replication. Human CDC6 activity is regulated by periodic transcription and CDK-regulated subcellular localization. Here, we show that, in addition to being absent from nonproliferating cells, CDC6 is targeted for ubiquitin-mediated proteolysis by the anaphase promoting complex (APC)/cyclosome in G1. A combination of point mutations in the destruction box and KEN-box motifs in CDC6 stabilizes the protein in G1 and in quiescent cells. Furthermore, APC, in association with CDH1, ubiquitinates CDC6 in vitro, and both APC and CDH1 are required and limiting for CDC6 proteolysis in vivo. Although a stable mutant of CDC6 is biologically active, overexpression of this mutant or wild-type CDC6 is not sufficient to induce multiple rounds of DNA replication in the same cell cycle. The APC–CDH1-dependent proteolysis of CDC6 in early G1 and in quiescent cells suggests that this process is part of a mechanism that ensures the timely licensing of replication origins during G1.

Keywords

Footnotes

  • 3 These authors contributed equally to this work.

  • 4 Corresponding author.

  • E-MAIL khelin{at}ieo.it; FAX 39-02-5748-9851.

  • Article and publication are at www.genesdev.org/cgi/doi/10.1101/gad.832500.

    • Received March 7, 2000.
    • Accepted July 20, 2000.
| Table of Contents

Life Science Alliance